Jeff Huntsman
Chief Commercial Officer
PCM Trials & EmVenio Research
Jeff Huntsman is the Chief Commercial Officer for PCM Trials and EmVenio Research, overseeing
commercial strategy and revenue growth. Mr. Huntsman joined PCM Trials in 2024 with more
than 30 years of experience in the Life Sciences space, where he has led global commercial
teams selling pharma services solutions across the clinical development and regulatory lifecycle.
Prior to joining PCM Trials, Mr. Huntsman ran a consulting firm providing strategic advice to
private equity, venture capital and emerging growth companies. Earlier in his career, he was the
Chief Commercial Officer at Sitero, Citeline, ConnectiveRx, and LIQUENT. He has held executive
leadership roles at Clarivate, Parexel, Thomson Reuters, and Rogers Communications as well as
having served as a Health Care Advisor at Warburg Pincus and Growth Capital Partners.